Inventor · disambiguated record
Sang Ryeol Shim
Also filed as: SHIM SANG RYEOL
8 granted patents·1 pending application·12 citations·filing 2007–2021
78Inventor score
Top patents by PatentIndex Score
9 records- 0187US10106622B2Human antibody specific to c-Met and preparation method thereofPHARMABCINE INC·Filed 2015·Granted Oct 23, 2018·9 cites·8 claims
- 0272US9150650B2Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereofYOO JIN-SAN·Filed 2007·Granted Oct 6, 2015·2 cites·6 claims
- 0366US9963512B2Dual-target antibody targeting VEGFR-2 and DLL4, and pharmaceutical composition including samePHARMABCINE INC·Filed 2013·Granted May 8, 2018·1 cites·4 claims
- 0466US9249219B2Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereofPHARMABCINE INC·Filed 2014·Granted Feb 2, 2016·0 cites·6 claims
- 0562US9249220B2Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereofPHARMABCINE INC·Filed 2014·Granted Feb 2, 2016·0 cites·6 claims
- 0655US10125194B2Dual targeting antibody of novel form, and use thereofYOO JIN SAN·Filed 2009·Granted Nov 13, 2018·0 cites·5 claims
- 0754US2023265196A1Combination Therapy of a PD-1 Antagonist and an Antagonist for VEGFR-2 for Treating Patients with CancerPHARMABCINE INC·Filed 2021·Application pending·0 cites
- 0850US10155817B2Dual-target antibody targeting VEGFR-2 and DLL4 and pharmaceutical composition including samePHARMABCINE INC·Filed 2018·Granted Dec 18, 2018·0 cites·8 claims
- 0947US10597457B2EGFRvIII antibody and composition comprising samePHARMABCINE INC·Filed 2014·Granted Mar 24, 2020·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Sang Ryeol Shim files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →